Login to Your Account

DIA China

China proposes streamlined regs to collect human genetic resources for clinical trials

By Shannon Ellis
Staff Writer

Wednesday, October 4, 2017

SUZHOU, China – At the 3rd DIA China Drug Discovery Innovation, a director from the Ministry of Science and Technology (MOST) outlined the government's proposed plans to accelerate approvals for the collection of human genetic resources in keeping with the central government's overall strategy to support innovative drug development.

To continue reading subscribe now to BioWorld Asia (formerly International)

Learn More about BioWorld Asia (formerly International)

Already a subscriber? Sign In or Buy now to activate your subscription